MICHELLE THOMPSON: Open Payments
NPI 1053064436 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,979 in 98 payments from 18 companies in 2025. Trend: 2023 $446 · 2024 $3,285 · 2025 $1,979
Food & beverage: $1,979
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $710 |
| Bayer Healthcare Pharmaceuticals Inc. | 15 | $286 |
| Alkermes, Inc. | 14 | $146 |
| Madrigal Pharmaceuticals | 1 | $106 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $104 |
| Novo Nordisk Inc | 6 | $103 |
| Otsuka America Pharmaceutical, Inc. | 5 | $95 |
| ViiV Healthcare Company | 5 | $93 |
| Exact Sciences Corporation | 4 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
Products named: VRAYLAR, Kerendia, MAVYRET, REXULTI, REZDIFFRA, TRINTELLIX, DOVATO, LYBALVI.
Industry payments across KY — which companies pay providers there.
